Annual Total Liabilities
$84.02 M
+$33.18 M+65.25%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual total liabilities is $84.02 million, with the most recent change of +$33.18 million (+65.25%) on December 31, 2023.
- During the last 3 years, AMLX annual total liabilities has risen by +$3.19 million (+3.95%).
- AMLX annual total liabilities is now -67.28% below its all-time high of $256.78 million, reached on December 31, 2021.
Performance
AMLX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$54.51 M
-$16.34 M-23.07%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly total liabilities is $54.51 million, with the most recent change of -$16.34 million (-23.07%) on September 30, 2024.
- Over the past year, AMLX quarterly total liabilities has increased by +$6.33 million (+13.13%).
- AMLX quarterly total liabilities is now -78.77% below its all-time high of $256.78 million, reached on December 31, 2021.
Performance
AMLX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AMLX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +65.3% | +13.1% |
| 3 y3 years | +4.0% | +13.1% |
| 5 y5 years | +194.0% | +13.1% |
AMLX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.3% | +65.3% | -78.8% | +68.0% |
| 5 y | 5-year | -67.3% | +194.0% | -78.8% | +68.0% |
| alltime | all time | -67.3% | +194.0% | -78.8% | +68.0% |
Amylyx Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $54.51 M(-23.1%) |
| Jun 2024 | - | $70.85 M(-23.8%) |
| Mar 2024 | - | $93.02 M(+10.7%) |
| Dec 2023 | $84.02 M(+65.2%) | $84.02 M(+74.4%) |
| Sep 2023 | - | $48.18 M(-28.3%) |
| Jun 2023 | - | $67.22 M(+21.5%) |
| Mar 2023 | - | $55.31 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $50.85 M(-80.2%) | $50.85 M(+35.9%) |
| Sep 2022 | - | $37.41 M(+15.3%) |
| Jun 2022 | - | $32.45 M(-3.1%) |
| Mar 2022 | - | $33.49 M(-87.0%) |
| Dec 2021 | $256.78 M(+217.7%) | $256.78 M(+0.9%) |
| Sep 2021 | - | $254.53 M(+214.9%) |
| Dec 2020 | $80.83 M(+182.8%) | $80.83 M |
| Dec 2019 | $28.58 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual total liabilities year-on-year change?
- What is Amylyx Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly total liabilities year-on-year change?
What is Amylyx Pharmaceuticals annual total liabilities?
The current annual total liabilities of AMLX is $84.02 M
What is the all time high annual total liabilities for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual total liabilities is $256.78 M
What is Amylyx Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, AMLX annual total liabilities has changed by +$33.18 M (+65.25%)
What is Amylyx Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of AMLX is $54.51 M
What is the all time high quarterly total liabilities for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly total liabilities is $256.78 M
What is Amylyx Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, AMLX quarterly total liabilities has changed by +$6.33 M (+13.13%)